Video & Transcript DataContr Research : 'FDA'

Page 1 of 8
US
Transcript Highlights:
  • span marker="129" data-time="1536">Moving on to the Food and Drug Administration, they've confirmed as FDA
  • Jay Bhattacharya, and the Commissioner of the FDA, Dr. Monty McCary.
  • Chairman, I will also oppose the FDA nominee. Thank you very much.
  • McCary had decided to elevate to the chief counsel of the FDA a lawyer from the Biden administration
  • She has resigned as chief counsel at the FDA.
Summary: The meeting focused on vital health-related nominations, primarily emphasizing the roles of Dr. Jay Bhattacharya for NIH Director and Dr. Monty McCary for FDA Commissioner. During the discussion, various senators expressed their support and concerns regarding these nominations. Senator Sanders voiced opposition to both candidates, highlighting issues related to drug affordability and public trust in health agencies. He emphasized the need for leaders committed to transparency and addressing the epidemic of high prescription drug prices, advocating for action against pharmaceutical industry greed. Overall, the conversation underscored the critical crossroads in public health leadership amidst ongoing challenges such as trust restoration and healthcare accessibility.
TX

Texas 2025 - 89th 2nd C.S.

Agriculture & Livestock Aug 19th, 2025 at 02:08 pm

House Agriculture & Livestock Committee

Transcript Highlights:
  • Kennedy Jr., and the FDA for authorizing the emergency measures.
  • From FDA today, does that allow y'all to deploy some?
  • Well, I think the FDA is thinking, if we have an...
  • What do y'all interpret today's announcement from the FDA to mean?
  • But it really comes down to the FDA, their given FDA clearance numbers.
Summary: The meeting of the Committee on Agriculture and Livestock addressed the ongoing threat of the New World Screw Worm, which poses significant risks to both livestock and wildlife in Texas. Chairman Kitzman emphasized the importance of a coordinated response among state and federal agencies, including the recent $750 million investment for a new sterile fly facility in south Texas, crucial for combating this threat. Several invited witnesses provided insights on current research, management strategies, and the collaboration needed to effectively handle potential infestations.
US
Transcript Highlights:
  • Not only do we want to encourage agencies such as the USPTO and the FDA to coordinate better on patents
Summary: The meeting focused on addressing the high cost of prescription drugs and the abusive practices that contribute to elevated prices affecting American families. Several bills were presented, including proposals to end pay-for-delay deals and to enhance transparency in the operations of pharmacy benefit managers (PBMs). The discussion was notable for its emphasis on consumer protection and ensuring that cheaper generic drugs reach the market more effectively. Members expressed frustration over past attempts to pass similar legislation stalling in the Senate, leading to renewed efforts to push these bills forward.
TX

Texas 2025 - 89th Regular

Health and Human Services (Part I) Apr 23rd, 2025

Senate Health & Human Services Committee

Transcript Highlights:
  • So when it comes to drugs, we are following the FDA...
  • Under this definition, there are quite a few instances where we would no longer be following those FDA
Summary: The meeting involved focused discussions on several key bills aimed at improving mental health services and regulatory practices within the state. Notably, Senator Sparks introduced SB2446, which aims to enhance transparency in Local Mental Health Authorities (LMHAs) by requiring detailed expenditure reports and reducing the influence of Diversity, Equity, and Inclusion (DEI) initiatives in decision-making processes. The bill drew mixed reactions, with some members emphasizing the need for more oversight while others raised concerns about potential negative impacts on recruitment and service delivery for vulnerable populations. Public testimony highlighted differing perspectives, underscoring the complexity of mental health policies and their implementation constraints.
TX

Texas 2025 - 89th Regular

Health and Human Services (Part II) Apr 23rd, 2025

Senate Health & Human Services Committee

Transcript Highlights:
  • Applicants must demonstrate the ability to, one, conduct and finance FDA-compliant drug development.
  • All research must be FDA IND approved.
  • The FDA is already looking extensively at ibogaine, so we think we'd be in alignment with what we're
  • On December 14, 1995, the FDA approved Purdue Pharmaceuticals' OxyContin for, quote, "the management
  • So how do we guarantee through the FDA approval process and the pharmaceutical industry?
Summary: During this meeting of the Senate Committee on Health and Human Services, significant attention was given to various bills aimed at enhancing healthcare provisions and improving processes within the health sector. Notable discussions included the presentation of Senate Bill 547 by Senator Menendez, which seeks to streamline provider notice requirements for healthcare professionals by proposing a centralized database managed by the Texas Department of Insurance. The bill was favorably reported and moved forward with recommendations for local and uncontested calendars. Additionally, a committee substitute for Senate Bill 2308 was introduced, focusing on innovative mental health treatments for veterans, particularly regarding ibogaine as a treatment for opioid use disorder. This proposal received strong support due to its potential to lead the nation in mental health care advancements.
TX

Texas 2025 - 89th Regular

Public Health Apr 28th, 2025 at 11:04 am

House Public Health Committee

Transcript Highlights:
  • So, when the FDA was asked by Congress to define very small
  • So we're very rapidly heading for the FDA defining very small food businesses as $1.34 million.
  • In the United States, the CDC, NIH, and FDA all define

Summary: During this meeting of the health committee, several key bills were discussed primarily focusing on health care practices and patient rights in Texas. In particular, House Bill 4553 drew significant attention as it aims to improve transparency in midwifery practices and ensure the safety of out-of-hospital births. Testimonies were presented both in support and opposition, with concerns raised by midwives regarding the implications of the bill on their practice and autonomy. Additionally, House Bill 3708, designed to assist those burdened by medical debt, was strongly supported by several witnesses bringing forth personal stories underscoring the need for improved access to charity care information. The meeting also covered discussions on organ transplant eligibility and informed consent related to vaccines, echoing larger public health considerations in the post-pandemic era.
TX

Texas 2025 - 89th Regular

89th Legislative Session May 19th, 2025 at 10:05 am

Texas House Floor Meeting

Summary: The committee's meeting was marked by several key discussions surrounding numerous bills and resolutions. Notably, HCR 9 and HCR 40 were adopted, with representatives urging Congress for reimbursement related to border security under Operation Lone Star. Additionally, HCR 118 showed expressions of support for the warship manufacturing industry, reflecting a strong emphasis on local economic development. Senate Bills 1321, 2143, and 2145 passed various readings, which included provisions regarding law enforcement authority and the adaptability of public improvement districts to conduct meetings virtually. The meeting was well attended and featured numerous votes on significant legislative items, showcasing active participation from both members and the public.
TX

Texas 2025 - 89th Regular

89th Legislative Session May 20th, 2025 at 10:05 am

Texas House Floor Meeting

Transcript Highlights:
  • the most common forms of cancer in the U.S. and is the most effective preventative measure, but the FDA
Summary: The committee meeting was marked by dynamic discussions surrounding various legislative bills, notably SB1283 aimed at enhancing security in senior retirement communities following tragic incidents in the past. The bill, presented by Ms. Garcia-Hernandez, outlined essential measures including mandatory background checks for staff and a clear communication policy on criminal activities. The meeting also saw vigorous debates on multiple financial resolutions related to the statewide budget surplus, emphasizing the need for strategic allocation to property tax relief, as voiced by several committee members. Tensions arose as representatives questioned local government spending, reflecting a broader concern over escalating taxes across the state.
TX

Texas 2025 - 89th Regular

Public Health Apr 21st, 2025 at 12:04 pm

House Public Health Committee

Transcript Highlights:
  • But again, that would require the FDA.
  • So Fauci at the FDA had the FDA declare it.
  • Mary and a few other doctors sued the FDA and they had to retry...
  • FDA approval to have Tylenol on the shelf. Yes.
  • Currently, these are the only FDA.
Summary: The Committee on Public Health convened to discuss various bills related to mental health, public health initiatives, and animal care. Notably, representatives presented House Bill 2264, which aims to facilitate communication between mental health patients and their families, allowing family members to provide important medical information during emergencies. The bill sparked a substantial discussion, with advocates from the National Alliance on Mental Illness supporting its intention to improve patient outcomes. Other significant bills included HB 1747, introduced to create a council for mental health and substance use, fostering collaboration among affected systems, and HB 2684, which focuses on palliative care options for parents facing life-limiting diagnoses for their unborn children. Public testimonies supported these measures, highlighting their importance in enhancing care and support for vulnerable populations.
TX

Texas 2025 - 89th Regular

89th Legislative Session May 31st, 2025 at 02:05 pm

Texas House Floor Meeting

Summary: The meeting involved extensive discussions around several key bills, with highlights focused on the implications of SB12, which emphasized the Texas Parent Bill of Rights. Members debated its potential impacts on educational practices, particularly concerning diversity and inclusion efforts in schools. Concerns were raised about how the removal of DEI programs could adversely affect students with disabilities, particularly those on the autism spectrum. Additionally, SB1506 was addressed, with a significant change proposed to include stricter regulations regarding fentanyl possession, reflecting ongoing concerns about substance abuse in the community. The meeting was well-attended, featuring participation from multiple representatives expressing opinions regarding these bills. The chair recognized various members to provide input, and all discussions culminated in multiple votes on the proposed conference committee reports. The atmosphere was charged as representatives weighed the consequences of these legislative actions on their constituents. In conclusion, the committee successfully adopted multiple measures and set the stage for further engagement on the legislative agenda ahead.
TX

Texas 2025 - 89th Regular

Senate Session May 31st, 2025

Texas Senate Floor Meeting

Transcript Highlights:
  • 21492"> Notably, the House version also removed detailed provisions regarding the drug's use following FDA
  • While the original bill referenced FDA-authorized trials,

  • in writing, will be responsible for submitting the investigational new drug (IND) application to the FDA
Bills: SB27, SB1494, SB2121, SB2373, SB2431, SB1, SB8, SB12, SB13, SB15, SB30, SB37, SB260, SB268, SB331, SB379, SB441, SB447, SB457, SB568, SB650, SB763, SB1405, SB1506, SB1540, SB1566, SB1610, SB1637, SB1660, SB2018, SB2024, SB2217, SB2308, SB2337, SB2601, SB2753, SB2878, SB2900, SB2972, SB3059, HB4, HB40, HB46, HB119, HB145, HB300, HB493, HB705, HB1545, HB2011, HB2017, HB2067, HB2516, HB2885, HB2963, HB2974, HB3071, HB3372, HB3556, HB3595, HB3642, HB3909, HB5138, HB5246, SJR36, SJR50, SJR63, SCR12, SCR39, SB2023, SB62, SB666, SB847, SB284, SB854, SB810, SB1505, SB583, SB507, SB1434, SB1772, SB2016, SB1122, SB731, SB397, SB508, SB1436, SB287, SB1882, SB393, SB1791, SB209, SB2429, SB1085, SB1975, SB2717, SB1262, SB636, SB2056, SB884, SB1200, SB1845, SB2458, SB801, SB3014, SB3013, SB758, SB2797, SB2076, SB2876, SB1640, SB1449, SB1181, SB1234, SB2926, SB2841, SB1528, SB1854, SB317, SB1250, SB2082, SB1237, SB2819, SB629, SB2608, SB1602, SB2009, SB867, SB640, SB1698, SB2680, SB913, SB1071, SB1086, SB1087, SB1483, SB1444, SB1553, SB1556, SB1703, SB2133, SB2297, SB2298, SB2622, SB2955, SB2334, SB1367, SB2044, SB2363, SB2565, SB1888, SB3036, SB3057, SB3043, SB3063, SB3035, SB203, SB2688, SB2522, SB2459, SB2655, SB2251, SB1884, SB2928, SB2566, SB2549, SB2553, SB2919, SB1944, SB1232, SB1798, SB2603, SB2607, SB2683, SB1319, SB3045, SB3071, HB796, HB1523, HB5294, HB748, HB3395, HB180, HB3171, HB146, HB5596, HB5694, HB1135, HB3225, HB186, HB1449, HB3793, HB112, HB104, HB3336, HB3520, HB3320, HB5663, HB2399, HB111, HB3483, HB4580, HB3748, HB632, HB4730, HB5690, HB5689, HB3385, HB4359, HB5381, HB123, HB5606, HB1057, HB3664, HCR141, HCR40, HCR59, SR634, SR687, SR703, SR709, SR715, SB1494, SB2121, SB2373, SB2431, HB46, SB1, SB8, SB12, SB13, SB15, SB37, SB260, SB331, SB379, SB441, SB447, SB457, SB568, SB763, SB1405, SB1540, SB1566, SB2018, SB2308, SB2337, SB2878, SB3059, HB705, HB2017, HB2067, HB3071, HB3372, HB3556, HB3595, HB3909, HB5246
Summary: The meeting focused on the discussions concerning Senate Bill 2308, aimed at advancing clinical trials related to Ibogaine treatment. Senator Parker highlighted the necessity of implementing detailed regulatory frameworks to ensure the safety and efficacy of the trials. The bill underwent substantial refinements, addressing eligibility criteria, funding oversight, and establishing fiscal safeguards before the Senate adopted it unanimously. Additionally, the conference committee reported on various other bills, including budget allocations for mental health and special education funding, emphasizing a commitment to fiscal responsibility while addressing critical community needs. The meeting was characterized by collaborative efforts among committee members to refine and support legislation that directly impacts Texan citizens.
TX

Texas 2025 - 89th Regular

Senate Session Jun 1st, 2025

Texas Senate Floor Meeting

Summary: The committee meeting held a comprehensive discussion on multiple bills, with significant focus on Senate Bill 2900 and its implications for streamlining agency oversight regarding advisory committees. Senator Sparks led the conversation, emphasizing the need for ensuring local communities maintain their input on critical funds essential for indigent health care, following amendments that were made in the House. Additionally, the conference committee reports for Senate Bill 2753, which deals with election code changes, and House Bill 46, focusing on prescription medication management, were passed with a strong bipartisan support, reflecting the commitment to improving state governance in these areas.
TX

Texas 2025 - 89th Regular

Senate Session (Part III) Apr 30th, 2025

Texas Senate Floor Meeting

Transcript Highlights:
  • There are reported deaths, even by the FDA, which has

  • None of that's required by the FDA.

Bills: HCR35, SJR59, SJR84, SCR30, SB127, SB317, SB324, SB457, SB506, SB511, SB529, SB547, SB584, SB619, SB636, SB646, SB659, SB715, SB732, SB735, SB771, SB784, SB800, SB801, SB904, SB1026, SB1049, SB1065, SB1181, SB1224, SB1250, SB1383, SB1467, SB1524, SB1528, SB1531, SB1568, SB1585, SB1640, SB1681, SB1754, SB1757, SB1777, SB1972, SB1980, SB2007, SB2041, SB2046, SB2050, SB2055, SB2069, SB2080, SB2119, SB2138, SB2139, SB2154, SB2201, SB2225, SB2268, SB2306, SB2308, SB2310, SB2330, SB2366, SB2375, SB2392, SB2401, SB2422, SB2480, SB2514, SB2530, SB2533, SB2543, SB2544, SB2589, SB2610, SB2615, SB2623, SB2660, SB2662, SB2693, SB2695, SB2707, SB2722, SB2742, SB2753, SB2807, SB2843, SB2844, SB2858, SB2880, SB2885, SB2891, SB2925, SB2938, SB2986, SJR3, SJR18, SB5, SB914, SB963, SB1197, SB1415, SB1437, SB1786, SB326, SB767, SB769, SB783, SB1035, SB1271, SB1619, SB1637, SB1806, SB1, SB260, HB135, HB1109, HCR35, HCR64, SJR36, SJR50, SJR63, SJR84, SJR59, SCR12, SCR39, SCR48, SCR19, SCR30, SCR3, SB2023, SB619, SB2742, SB646, SB1026, SB2880, SB62, SB666, SB847, SB284, SB854, SB1073, SB810, SB1505, SB583, SB1502, SB507, SB1434, SB1376, SB1585, SB1772, SB2016, SB1163, SB1122, SB731, SB397, SB508, SB1436, SB287, SB261, SB1882, SB393, SB1791, SB529, SB209, SB2429, SB1999, SB511, SB2309, SB510, SB584, SB1085, SB2046, SB1975, SB2717, SB1262, SB1524, SB636, SB2056, SB884, SB517, SB1200, SB1845, SB1863, SB2681, SB2200, SB2199, SB1757, SB2050, SB2458, SB2201, SB2660, SB2662, SB1065, SB801, SB2533, SB3014, SB3013, SB758, SB1721, SB2366, SB1013, SB2797, SB2383, SB1754, SB2119, SB2448, SB1777, SB1283, SB2392, SB2076, SB2786, SB2876, SB2284, SB2225, SB1540, SB2929, SB1972, SB2540, SB2595, SB2217, SB715, SB2330, SB1383, SB500, SB1640, SB2001, SB2080, SB506, SB2514, SB2753, SB2398, SB1241, SB2927, SB2173, SB2538, SB898, SB1449, SB2529, SB1531, SB2846, SB2476, SB986, SB1181, SB2075, SB2154, SB2864, SB1359, SB2386, SB771, SB2844, SB2550, SB1351, SB1423, SB1931, SB2245, SB2589, SB2707, SB2807, SB410, SB659, SB2776, SB2693, SB2580, SB1980, SB1886, SB1234, SB739, SB456, SB127, SB1666, SB2843, SB2801, SB800, SB2055, SB784, SB2986, SB735, SB1012, SB324, SB2926, SB2938, SB2007, SB2138, SB1242, SB2615, SB1049, SB2310, SB1224, SB2972, SB1568, SB2841, SB2885, SB3016, SB2858, SB2610, SB2139, SB1856, SB2035, SB2308, SB2306, SB2041, SB1528, SB1681, SB1141, SB2401, SB2530, SB2375, SB547, SB1266, SB1373, SB1467, SB2069, SB2269, SB2480, SB2544, SB672, SB904, SB2695, SB2891, SB2422, SB2543, SB1854, SB317, SB2539, SB2532, SB2925, SB1250, SB2082, SB2203, SB457, SB2357, SB2721, SB243, SB1285, SB2568, SB1959, SB1442, SB1454, SB2520, SB2541, SB1708, SB1237, SB1844, SB1586, HB1392, HB22, SB1551, SB3039, SB2819, SB66, SB629, SB1015, SB2342, SB2903, SB2933, SB1965, SB2477, SB3029, SB2605, SB2419, SB1957, SB375, SB250, SB777, SB628, SB2523, SB2367, SB2703, SB2608, SB2778, SB3044, SB2965, SB2521, SB865
Summary: The recent committee meeting included significant discussions surrounding several controversial bills focusing on abortion rights and election laws. Notably, Senate Bill 2880 was heavily debated, with Senator Alvarado expressing strong opposition, suggesting that it imposed a de facto travel ban on women seeking abortion services outside Texas. He cited that the bill would threaten families and friends who assist in accessing legal abortion care, emphasizing the potential revival of outdated and punitive abortion laws in the state. Additionally, members raised concerns about the bill simultaneously undermining constitutional rights and infringing upon the independence of the judiciary by creating civil liabilities for those involved in providing abortion-inducing medications, regardless of legality in other states. Other bills discussed included Senate Bill 1026, which restored powers to the Attorney General to prosecute election crimes, and Senate Bill 1754 concerning tax exemptions for renewable energy facilities. The meeting showcased a mixture of support and dissent among senators, reflecting the contentious political climate regarding these issues. As the session concluded, many members expressed intentions to vocalize additional concerns on the implications of these legislative measures in forthcoming discussions.
TX

Texas 2025 - 89th Regular

Senate Session Apr 29th, 2025

Texas Senate Floor Meeting

Transcript Highlights:
  • But I want to stress that the FDA does not recommend buying prescription drugs online.
  • This is part of the FDA drug safety program that they...
  • But that's not happening, nor is the FDA investigating the harm.
  • The FDA reports 36 that I'm aware of.
  • It is different, and of course that's the FDA.

Bills: SJR59, SCR30, SCR46, SB31, SB127, SB324, SB401, SB407, SB467, SB482, SB506, SB529, SB584, SB619, SB636, SB646, SB647, SB659, SB715, SB732, SB735, SB771, SB784, SB800, SB801, SB816, SB1013, SB1026, SB1049, SB1055, SB1065, SB1137, SB1169, SB1181, SB1383, SB1395, SB1410, SB1433, SB1524, SB1531, SB1568, SB1640, SB1666, SB1681, SB1718, SB1754, SB1757, SB1972, SB1980, SB2004, SB2007, SB2041, SB2046, SB2050, SB2075, SB2076, SB2154, SB2173, SB2206, SB2225, SB2253, SB2268, SB2306, SB2308, SB2314, SB2322, SB2330, SB2351, SB2366, SB2371, SB2392, SB2398, SB2476, SB2533, SB2540, SB2544, SB2589, SB2610, SB2623, SB2660, SB2662, SB2693, SB2707, SB2717, SB2722, SB2742, SB2753, SB2779, SB2807, SB2843, SB2844, SB2858, SB2877, SB2880, SB2885, SB2920, SB2938, SB2986, HJR4, HCR35, SJR3, SJR18, SB5, SB260, SB1786, SB914, SB963, SB1197, SB1415, SB1437, SJR36, SJR50, SJR63, SJR84, SJR59, SCR12, SCR39, SCR46, SCR48, SCR19, SCR30, SCR3, SB2023, SB1433, SB2322, SB2877, SB407, SB1718, SB1395, SB62, SB666, SB847, SB284, SB854, SB1073, SB810, SB1505, SB583, SB1502, SB507, SB1026, SB1434, SB1376, SB1585, SB1772, SB2016, SB1163, SB619, SB1122, SB732, SB731, SB397, SB508, SB1436, SB287, SB261, SB1882, SB393, SB1791, SB529, SB209, SB2429, SB1999, SB511, SB2309, SB510, SB2253, SB584, SB1085, SB2314, SB2046, SB1975, SB2717, SB1262, SB1524, SB1137, SB636, SB2056, SB884, SB517, SB1200, SB1410, SB1845, SB1863, SB2681, SB2200, SB2199, SB1757, SB2050, SB2458, SB2201, SB1055, SB2660, SB2662, SB1065, SB801, SB2533, SB3014, SB3013, SB758, SB647, SB1721, SB2268, SB2366, SB1013, SB2797, SB2371, SB2383, SB646, SB1169, SB1754, SB2779, SB2004, SB2119, SB2448, SB1777, SB1283, SB2392, SB2076, SB2786, SB2876, SB2284, SB2225, SB1540, SB2920, SB2929, SB1972, SB2540, SB2742, SB2595, SB2217, SB715, SB2330, SB1383, SB500, SB1640, SB2001, SB2080, SB2722, SB506, SB2514, SB2623, SB2753, SB2398, SB1241, SB2927, SB2173, SB2538, SB898, SB467, SB1449, SB2529, SB1531, SB2846, SB2476, SB986, SB1181, SB2075, SB2154, SB2864, SB31, SB2880, SB1359, SB2386, SB771, SB2844, SB2550, SB1351, SB1423, SB1931, SB2245, SB2589, SB2707, SB2807, SB2351, SB410, SB659, SB816, SB2776, SB2693, SB2580, SB1980, SB1886, SB1234, SB739, SB482, SB456, SB127, SB1666, SB2843, SB2801, SB800, SB2055, SB784, SB2986, SB735, SB1012, SB324, SB2926, SB2938, SB2007, SB2138, SB1242, SB2615, SB1049, SB2310, SB1224, SB2972, SB1568, SB2841, SB2885, SB3016, SB2858, SB2610, SB2139, SB1856, SB2035, SB2308, SB2306, SB2041, SB1528, SB1681, SB1141, SB2401, SB2530, SB2375, SB547, SB1266, SB1373, SB1467, SB2069, SB2269, SB2480, SB2544, SB672, SB904, SB2695, SB2891, SB2422, SB2543, SB1854, SB317, SB2539, SB2532, SB2925, SB1250, SB2082, SB2203, SB457, SB2357, HJR4, HB135, HB1109, HCR35, HCR64, SB2721, SB243, SB1285, SB2568, SB1959, SB1442, SB1454, SB2520, SB2541, SB1708, SB1237, SB1844, SB1586
Summary: During the committee meeting, several significant bills were discussed and passed, reflecting a range of legislative priorities. Notably, SB816, which authorizes the disclosure of certain electronic customer data by electronic communication service providers, was brought to a vote after a successful amendment that clarified its application to law enforcement agencies. The bill passed with support, garnering 27 ayes against 4 nays. In a parallel concern for public safety, SB482 was also passed, which increases criminal penalties for assault and harassment against utility workers, acknowledging the essential services they provide, especially during crises. The passage of this bill was an effort to reinforce protections for those in vulnerable positions during emergencies.
TX

Texas 2025 - 89th Regular

Senate Session (Part II) Apr 30th, 2025

Texas Senate Floor Meeting

Bills: HCR35, SJR59, SJR84, SCR30, SB127, SB317, SB324, SB457, SB506, SB511, SB529, SB547, SB584, SB619, SB636, SB646, SB659, SB715, SB732, SB735, SB771, SB784, SB800, SB801, SB904, SB1026, SB1049, SB1065, SB1181, SB1224, SB1250, SB1383, SB1467, SB1524, SB1528, SB1531, SB1568, SB1585, SB1640, SB1681, SB1754, SB1757, SB1777, SB1972, SB1980, SB2007, SB2041, SB2046, SB2050, SB2055, SB2069, SB2080, SB2119, SB2138, SB2139, SB2154, SB2201, SB2225, SB2268, SB2306, SB2308, SB2310, SB2330, SB2366, SB2375, SB2392, SB2401, SB2422, SB2480, SB2514, SB2530, SB2533, SB2543, SB2544, SB2589, SB2610, SB2615, SB2623, SB2660, SB2662, SB2693, SB2695, SB2707, SB2722, SB2742, SB2753, SB2807, SB2843, SB2844, SB2858, SB2880, SB2885, SB2891, SB2925, SB2938, SB2986, SJR3, SJR18, SB5, SB914, SB963, SB1197, SB1415, SB1437, SB1786, SB326, SB767, SB769, SB783, SB1035, SB1271, SB1619, SB1637, SB1806, SB1, SB260, HB135, HB1109, HCR35, HCR64, SJR36, SJR50, SJR63, SJR84, SJR59, SCR12, SCR39, SCR48, SCR19, SCR30, SCR3, SB2023, SB619, SB2742, SB646, SB1026, SB2880, SB62, SB666, SB847, SB284, SB854, SB1073, SB810, SB1505, SB583, SB1502, SB507, SB1434, SB1376, SB1585, SB1772, SB2016, SB1163, SB1122, SB731, SB397, SB508, SB1436, SB287, SB261, SB1882, SB393, SB1791, SB529, SB209, SB2429, SB1999, SB511, SB2309, SB510, SB584, SB1085, SB2046, SB1975, SB2717, SB1262, SB1524, SB636, SB2056, SB884, SB517, SB1200, SB1845, SB1863, SB2681, SB2200, SB2199, SB1757, SB2050, SB2458, SB2201, SB2660, SB2662, SB1065, SB801, SB2533, SB3014, SB3013, SB758, SB1721, SB2366, SB1013, SB2797, SB2383, SB1754, SB2119, SB2448, SB1777, SB1283, SB2392, SB2076, SB2786, SB2876, SB2284, SB2225, SB1540, SB2929, SB1972, SB2540, SB2595, SB2217, SB715, SB2330, SB1383, SB500, SB1640, SB2001, SB2080, SB506, SB2514, SB2753, SB2398, SB1241, SB2927, SB2173, SB2538, SB898, SB1449, SB2529, SB1531, SB2846, SB2476, SB986, SB1181, SB2075, SB2154, SB2864, SB1359, SB2386, SB771, SB2844, SB2550, SB1351, SB1423, SB1931, SB2245, SB2589, SB2707, SB2807, SB410, SB659, SB2776, SB2693, SB2580, SB1980, SB1886, SB1234, SB739, SB456, SB127, SB1666, SB2843, SB2801, SB800, SB2055, SB784, SB2986, SB735, SB1012, SB324, SB2926, SB2938, SB2007, SB2138, SB1242, SB2615, SB1049, SB2310, SB1224, SB2972, SB1568, SB2841, SB2885, SB3016, SB2858, SB2610, SB2139, SB1856, SB2035, SB2308, SB2306, SB2041, SB1528, SB1681, SB1141, SB2401, SB2530, SB2375, SB547, SB1266, SB1373, SB1467, SB2069, SB2269, SB2480, SB2544, SB672, SB904, SB2695, SB2891, SB2422, SB2543, SB1854, SB317, SB2539, SB2532, SB2925, SB1250, SB2082, SB2203, SB457, SB2357, SB2721, SB243, SB1285, SB2568, SB1959, SB1442, SB1454, SB2520, SB2541, SB1708, SB1237, SB1844, SB1586, HB1392, HB22, SB1551, SB3039, SB2819, SB66, SB629, SB1015, SB2342, SB2903, SB2933, SB1965, SB2477, SB3029, SB2605, SB2419, SB1957, SB375, SB250, SB777, SB628, SB2523, SB2367, SB2703, SB2608, SB2778, SB3044, SB2965, SB2521, SB865
Summary: The committee meeting centered around various legislative efforts, with a significant focus on Senate Bill proposals addressing issues such as medical claims mediation, human smuggling, and competitive bidding regulations. Senators discussed the implications of SB2544, which seeks to align mediation and arbitration options for out-of-network medical claims, and SB2046 aimed at enhancing penalties for bid rigging. The bill on human smuggling, SB659, received considerable attention as members underscored the seriousness of addressing corruption and criminal activities involving government resources. Overall, the meeting showcased a collective effort to advance critical legislation to safeguard public interests.
TX

Texas 2025 - 89th Regular

Senate Session (Part I) Apr 30th, 2025

Texas Senate Floor Meeting

Transcript Highlights:
  • Bill 2308 creates a public-private grant program through the Health and Human Services Agency to fund FDA-approved
  • A committee and a Texas-based IRB will oversee the trials, ensuring all research is FDA approved.
Bills: HCR35, SJR59, SJR84, SCR30, SB127, SB317, SB324, SB457, SB506, SB511, SB529, SB547, SB584, SB619, SB636, SB646, SB659, SB715, SB732, SB735, SB771, SB784, SB800, SB801, SB904, SB1026, SB1049, SB1065, SB1181, SB1224, SB1250, SB1383, SB1467, SB1524, SB1528, SB1531, SB1568, SB1585, SB1640, SB1681, SB1754, SB1757, SB1777, SB1972, SB1980, SB2007, SB2041, SB2046, SB2050, SB2055, SB2069, SB2080, SB2119, SB2138, SB2139, SB2154, SB2201, SB2225, SB2268, SB2306, SB2308, SB2310, SB2330, SB2366, SB2375, SB2392, SB2401, SB2422, SB2480, SB2514, SB2530, SB2533, SB2543, SB2544, SB2589, SB2610, SB2615, SB2623, SB2660, SB2662, SB2693, SB2695, SB2707, SB2722, SB2742, SB2753, SB2807, SB2843, SB2844, SB2858, SB2880, SB2885, SB2891, SB2925, SB2938, SB2986, SJR3, SJR18, SB5, SB914, SB963, SB1197, SB1415, SB1437, SB1786, SB326, SB767, SB769, SB783, SB1035, SB1271, SB1619, SB1637, SB1806, SB1, SB260, HB135, HB1109, HCR35, HCR64, SJR36, SJR50, SJR63, SJR84, SJR59, SCR12, SCR39, SCR48, SCR19, SCR30, SCR3, SB2023, SB619, SB2742, SB646, SB1026, SB2880, SB62, SB666, SB847, SB284, SB854, SB1073, SB810, SB1505, SB583, SB1502, SB507, SB1434, SB1376, SB1585, SB1772, SB2016, SB1163, SB1122, SB731, SB397, SB508, SB1436, SB287, SB261, SB1882, SB393, SB1791, SB529, SB209, SB2429, SB1999, SB511, SB2309, SB510, SB584, SB1085, SB2046, SB1975, SB2717, SB1262, SB1524, SB636, SB2056, SB884, SB517, SB1200, SB1845, SB1863, SB2681, SB2200, SB2199, SB1757, SB2050, SB2458, SB2201, SB2660, SB2662, SB1065, SB801, SB2533, SB3014, SB3013, SB758, SB1721, SB2366, SB1013, SB2797, SB2383, SB1754, SB2119, SB2448, SB1777, SB1283, SB2392, SB2076, SB2786, SB2876, SB2284, SB2225, SB1540, SB2929, SB1972, SB2540, SB2595, SB2217, SB715, SB2330, SB1383, SB500, SB1640, SB2001, SB2080, SB506, SB2514, SB2753, SB2398, SB1241, SB2927, SB2173, SB2538, SB898, SB1449, SB2529, SB1531, SB2846, SB2476, SB986, SB1181, SB2075, SB2154, SB2864, SB1359, SB2386, SB771, SB2844, SB2550, SB1351, SB1423, SB1931, SB2245, SB2589, SB2707, SB2807, SB410, SB659, SB2776, SB2693, SB2580, SB1980, SB1886, SB1234, SB739, SB456, SB127, SB1666, SB2843, SB2801, SB800, SB2055, SB784, SB2986, SB735, SB1012, SB324, SB2926, SB2938, SB2007, SB2138, SB1242, SB2615, SB1049, SB2310, SB1224, SB2972, SB1568, SB2841, SB2885, SB3016, SB2858, SB2610, SB2139, SB1856, SB2035, SB2308, SB2306, SB2041, SB1528, SB1681, SB1141, SB2401, SB2530, SB2375, SB547, SB1266, SB1373, SB1467, SB2069, SB2269, SB2480, SB2544, SB672, SB904, SB2695, SB2891, SB2422, SB2543, SB1854, SB317, SB2539, SB2532, SB2925, SB1250, SB2082, SB2203, SB457, SB2357, SB2721, SB243, SB1285, SB2568, SB1959, SB1442, SB1454, SB2520, SB2541, SB1708, SB1237, SB1844, SB1586, HB1392, HB22, SB1551, SB3039, SB2819, SB66, SB629, SB1015, SB2342, SB2903, SB2933, SB1965, SB2477, SB3029, SB2605, SB2419, SB1957, SB375, SB250, SB777, SB628, SB2523, SB2367, SB2703, SB2608, SB2778, SB3044, SB2965, SB2521, SB865
Summary: The committee meeting featured extensive discussions surrounding a variety of bills, notably focusing on topics including the regulation of referral agencies for senior living communities and adjustments to the processes related to election petitions and ballot propositions. Senators presented and debated several significant bills including SB506 and SB1383, which aim to clarify procedures for elections and provide accountability for professionals on child abuse reporting, respectively. Each bill saw motions for passage without substantial opposition, reflecting smooth progress through the legislative agenda. The discussions were well-attended, featuring voices from both committee members and the public.
TX

Texas 2025 - 89th 2nd C.S.

Public Health Aug 22nd, 2025 at 09:08 am

House Public Health Committee

Transcript Highlights:
  • In what context is it FDA approved for prescription?
  • The FDA has not approved this for COVID-19 use.
  • Once the federal agency, FDA, has determined.
  • That's why the FDA classifies them the way they do.
  • But the FDA does have adverse...
Bills: HB265, HB25
Summary: In this meeting of the Public Health Committee, the primary focus was on youth camp safety and legislation designed to address serious regulatory gaps. Representative Hull presented HB265, which aims to reform the oversight of youth camps to ensure better safety protocols and stricter regulations. The emotional testimony from families affected by past incidents highlighted the urgent need for change and accountability in camp operations. Representatives discussed necessary amendments to the bill, emphasizing the inclusion of child safety experts on the advisory committee and proposing measures to improve the enforcement of safety standards.
TX

Texas 2025 - 89th Regular

Public Health Apr 7th, 2025 at 03:30 pm

House Public Health Committee

Transcript Highlights:
  • Under the FDA situation, none of that has to be disclosed.
  • Not just the FDA. The USDA historically...
  • market, unlike the FDA.
  • The FDA approves medicines that they're feeding to their animals.
  • That's when the FDA jurisdiction ends—when the animal is slaughtered.
Summary: The meeting of the public health committee focused on the pressing issue of opioid addiction in Texas, with a particular emphasis on House Bill 3717. Chairman Harris detailed the bill's intent to fund a grant program for Ibogaine clinical trials, framing it as a critical response to the ongoing opioid crisis. He shared poignant testimonies highlighting the struggles of families and veterans battling addiction and mental health issues. The conversation underscored the necessity of innovative treatments, like Ibogaine, which showed promising results in studies for reducing symptoms of withdrawal and PTSD.
TX

Texas 2025 - 89th 2nd C.S.

Senate Session (Part III) Aug 27th, 2025

Texas Senate Floor Meeting

Transcript Highlights:
  • It is not FDA-approved for human consumption on viruses.
  • It is FDA approved.
  • In humans, drugs are approved through the FDA.
  • The FDA and only the FDA, which is currently headed

  • prescription drugs, i.e., FDA legend drugs, without a prescription.
Bills: SB3, SB16, SB2, SB5, SB10, HB17, SB54, SB9, SB7, SB17, SB4, HB8, HB25, HB26, HB192
Summary: The meeting featured extensive discussions centered on several legislative bills, particularly focusing on House Bill 8, which aims to reform public school accountability and testing methods in Texas. The bill's sponsor passionately argued for its transformative potential, highlighting the replacement of the STAAR test with shorter, more frequent assessments to better measure student performance. Amendments were proposed to restore social studies testing, emphasizing the importance of history in Texas education. The bill ultimately passed with a vote of 21 ayes and 5 nays, showcasing strong support among the members.

Research Filters

States
Terms / Sessions
Date Range
Chamber Records
Meetings / Events / Calendars